U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685821) titled 'In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment' on June 29.
Brief Summary: Open-label, non-randomized single-arm prospective, single-center, self-controlled clinical study.
Study Start Date: Dec. 22, 2025
Study Type: INTERVENTIONAL
Condition:
Lax Skin
Lifting
Improve Facial Wrinkles
Intervention:
DEVICE: Sofwave
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues. Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the ...